Samia Tasneem Pinkee

Currently serving as an Interventional Fellow at Bankstown-Lidcombe Hospital, Sydney, with advanced procedural skills in coronary angiography, PCI, intravascular imaging (IVUS, OCT), coronary physiology assessment (FFR, iFR), pericardiocentasis, echocardiogram. Previously completed two-years of Heart Failure and Transplant Fellowship at St. Vincent’s Hospital, gaining extensive experience managing heart transplant and mechanical circulatory support patients, performing cardiac biopsies and right heart catheterization, and contributing to multidisciplinary care across acute and ambulatory settings.

Before relocating to Australia, I worked for four years as a Consultant in General and Interventional Cardiology at the National Institute of Cardiovascular Diseases (NICVD), Dhaka — the country’s leading cardiac referral institute.

I hold an MSc in Clinical Trials from the University of Oxford, which has strengthened my expertise in evidence-based medicine and the conduct of large-scale randomised controlled trials. I am currently leading a research study involving a large cohort of PCI patients in NSW, with focus on outcomes in high-risk subgroups including those with chronic kidney disease.

With 15 years of postgraduate experience, a strong academic background, and a deep commitment to clinical excellence and ongoing professional development, I aim to contribute meaningfully as an interventional cardiologist.

AHPRA Specialist Registration in Cardiology

Interventional Cardiology

Clinical Trial experience as Co investigator/sub-investigator

Mar-24 TROPOS: KER012-A201 – PAH (plb vs drug for 24 weeks then long-term extension and active drug)

Feb-24 ROR-PH-301: Ralinepag -PAH (plb vs drug – Parent study)

Nov-23 ROR-PH-303: Ralinepag – PAH (open label)

Nov-23 SOTERIA: Sotatercept – PAH (open label) July-23 ZENITH: Sotatercept – PAH ( plb vs drug) mortality study

July-23 ODYSSEY: Mavacemten – nHCM ( plb vs drug for 48 weeks then long term extension and active drug)

Published Research work

• 11/2023 1st Author Plateletcrit: A Novel Risk Predictor of Acute Myocardial Infarction Nov 2023, Circulation.2023;148:13525. https://doi.org/10.1161/circ.148.suppl_1.13525
• 12/2020 1st author “Plateletcrit as a Novel Biomarker of Acute MI In Young Patients”, Bangla Cardio Journal, December 2020
• 07/2020 1st author “Association of Plateletcrit with acute MI in young patients as an emerging risk factor”, Bangladesh Journal of Cardiovascular Intervention. vol. 02, no. 02(July 2020)
• 08/2022 1st author (Book chapter) Book “Evolution of health sector of Bangladesh” Chapter: ‘Prevention of non-communicable diseases including cardiovascular diseases’ (Bangladesh health Watch, 2022)
• 09/2022 2nd author “A cardiologist’s nightmare: Ventricular septal rupture with cardiogenic shock follows by acute myocardial infarction.” Acta Colombiana de Cuidado Intensivo. https://doi.org/10.1016/J.ACCI.2021.05.002
• 07/2021 Co-author “Difficulties to enter the left ventricle during percutaneous transvenous mitral commissurotomy (PTMC)- our experiences of 80 cases with modified technique”, Indian Heart Journal, July 2021.
• 03/2021 Co-author “Past, Present & Future of Cardiovascular Diseases in Bangladesh”, National policy 2021
• 10/2023 Co-author "Safe femoral" artery approach in endovascular procedures: a systematic review of its safety and feasibility. October, 2023. CP Cardiol. https://pubmed.ncbi.nlm.nih.gov/37802172/

• tasneemsamia61@gmail.com
• samia.pinkee@health.nsw.gov.au

• Member, European Society of Cardiology (ESC)
• Member, American Heart Association (AHA)
• Registered Medical Practitioner – Australian Health Practitioner Regulation Agency (AHPRA)
• Former Consultant Cardiologist – National Institute of Cardiovascular Diseases (NICVD), Dhaka
• Alumni – University of Oxford, Green Templeton College